Associations - BRCA2 mutation + CHEK2 mutation

BIOMARKER:

BRCA2 mutation + CHEK2 mutation

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

BRCA2 mutation + CHEK2 mutation BRCA2 mutation + CHEK2 mutation	Prostate Cancer Prostate Cancer	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3
BRCA2 mutation + CHEK2 mutation BRCA2 mutation + CHEK2 mutation	Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma	FOLFIRINOX Sensitive: C4 – Case Studies FOLFIRINOX Sensitive : C4